NCT05998135 2025-09-11
Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer
Emory University
Phase 2 Recruiting
Emory University
Abramson Cancer Center at Penn Medicine
Charite University, Berlin, Germany
Dana-Farber Cancer Institute